Search research articles
Contact Us
Filters
Showing results (51-60 of 459) with videos related to
Page
of 46
Sort By:
Bioorganic & Medicinal Chemistry
|
October 17, 2020
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells
James E Melnyk, Veronica Steri, Hao G Nguyen, et al.
American Journal of Clinical Oncology
|
February 4, 2014
Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy
Jeffrey M Vainshtein, Matthew Schipper, Sean Vance, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 16, 2020
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions
Rana R McKay, Felix Y Feng, Alice Y Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2011
Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease
Matthew H Stenmark, Kevin Blas, Schuyler Halverson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 8, 2011
Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy
Sean M Vance, Matthew H Stenmark, Kevin Blas, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 29, 2009
Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer
Iris Gluck, Felix Y Feng, Teresa Lyden, et al.
NPJ Genomic Medicine
|
February 23, 2024
Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer
Debanjan Saha, Ha X Dang, Meng Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 21, 2007
Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation
Carlos A Lopez, Felix Y Feng, Joseph M Herman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2013
Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy
Mark Shilkrut, P William McLaughlin, Gregory S Merrick, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 10, 2010
Role of radiotherapy in the management of desmoid tumors
Iris Gluck, Kent A Griffith, J Sybil Biermann, et al.
Page
of 46
Search research articles
Search
Showing results (51-60 of 459) with videos related to
Sort By:
Page
of 46
Bioorganic & Medicinal Chemistry
|
October 17, 2020
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells
James E Melnyk, Veronica Steri, Hao G Nguyen, et al.
American Journal of Clinical Oncology
|
February 4, 2014
Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy
Jeffrey M Vainshtein, Matthew Schipper, Sean Vance, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 16, 2020
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions
Rana R McKay, Felix Y Feng, Alice Y Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2011
Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease
Matthew H Stenmark, Kevin Blas, Schuyler Halverson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 8, 2011
Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy
Sean M Vance, Matthew H Stenmark, Kevin Blas, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 29, 2009
Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer
Iris Gluck, Felix Y Feng, Teresa Lyden, et al.
NPJ Genomic Medicine
|
February 23, 2024
Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer
Debanjan Saha, Ha X Dang, Meng Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 21, 2007
Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation
Carlos A Lopez, Felix Y Feng, Joseph M Herman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2013
Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy
Mark Shilkrut, P William McLaughlin, Gregory S Merrick, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 10, 2010
Role of radiotherapy in the management of desmoid tumors
Iris Gluck, Kent A Griffith, J Sybil Biermann, et al.
Page
of 46